Disease | pancreatic cancer |
Phenotype | C0027947|neutropenia |
Sentences | 2 |
PubMedID- 22024222 | Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine therapy. |
PubMedID- 22133387 | The rrs of severe neutropenia were lowest in patients with pancreatic cancer treated with cetuximab compared with controls (rr 1.02; 95% ci 0.79, 1.31; fixed-effect model: and rr 1.06; 95% ci 0.72, 1.55; random-effects model), and highest in patients with squamous cell carcinoma of the esophagus (rr 1.64; 95% ci 0.53, 5.04; fixed-effect model: and rr 1.64; 95% ci 0.53, 5.04; random-effects model). |
Page: 1